ATE439443T1 - NEUES Aß-BINDUNGSPROTEIN UND DESSEN PEPTIDDERIVATE SOWIE VERWENDUNGEN DAVON - Google Patents
NEUES Aß-BINDUNGSPROTEIN UND DESSEN PEPTIDDERIVATE SOWIE VERWENDUNGEN DAVONInfo
- Publication number
- ATE439443T1 ATE439443T1 AT06752809T AT06752809T ATE439443T1 AT E439443 T1 ATE439443 T1 AT E439443T1 AT 06752809 T AT06752809 T AT 06752809T AT 06752809 T AT06752809 T AT 06752809T AT E439443 T1 ATE439443 T1 AT E439443T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide derivatives
- new
- binding protein
- disease
- disclosed
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 101710175516 14 kDa zinc-binding protein Proteins 0.000 abstract 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 abstract 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 abstract 1
- 102000003923 Protein Kinase C Human genes 0.000 abstract 1
- 108090000315 Protein Kinase C Proteins 0.000 abstract 1
- 229940123924 Protein kinase C inhibitor Drugs 0.000 abstract 1
- 230000008499 blood brain barrier function Effects 0.000 abstract 1
- 210000001218 blood-brain barrier Anatomy 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000003881 protein kinase C inhibitor Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69124805P | 2005-06-17 | 2005-06-17 | |
| PCT/CA2006/000990 WO2006133566A1 (en) | 2005-06-17 | 2006-06-16 | NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE439443T1 true ATE439443T1 (de) | 2009-08-15 |
Family
ID=37531931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06752809T ATE439443T1 (de) | 2005-06-17 | 2006-06-16 | NEUES Aß-BINDUNGSPROTEIN UND DESSEN PEPTIDDERIVATE SOWIE VERWENDUNGEN DAVON |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8323925B2 (de) |
| EP (1) | EP1896588B1 (de) |
| AT (1) | ATE439443T1 (de) |
| CA (1) | CA2611054C (de) |
| DE (1) | DE602006008460D1 (de) |
| ES (1) | ES2329511T3 (de) |
| WO (1) | WO2006133566A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0803912D0 (en) * | 2008-02-29 | 2008-05-07 | Univ Bristol | Novel Uses of VEGFxxxb |
| GB0804496D0 (en) | 2008-03-11 | 2008-04-16 | Theryte Ltd | Treating cancer |
| KR102099462B1 (ko) | 2010-11-30 | 2020-04-10 | 제넨테크, 인크. | 저친화도 혈액-뇌 장벽 수용체 항체 및 그의 용도 |
| US11034739B2 (en) | 2015-11-13 | 2021-06-15 | The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada | Ligand-guided phagocytosis based therapy for treatment of Alzheimer's disease and other neurodegenerative diseases |
| CN110382522A (zh) * | 2017-01-30 | 2019-10-25 | 加拿大国家研究委员会 | 血脑屏障穿过化合物及其用途 |
| US20240002437A1 (en) * | 2020-10-30 | 2024-01-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods of treating inflammatory lung diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5385915A (en) * | 1990-05-16 | 1995-01-31 | The Rockefeller University | Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation |
| AU2001263006A1 (en) | 2000-05-18 | 2001-11-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| AU2002304814A1 (en) | 2001-03-14 | 2002-11-05 | Hybrigenics | Protein-protein interactions in adipocytes |
| WO2003062391A2 (en) * | 2002-01-18 | 2003-07-31 | Incyte Corporation | Structural and cytoskeleton-associated proteins |
-
2006
- 2006-06-16 ES ES06752809T patent/ES2329511T3/es active Active
- 2006-06-16 WO PCT/CA2006/000990 patent/WO2006133566A1/en active Application Filing
- 2006-06-16 AT AT06752809T patent/ATE439443T1/de not_active IP Right Cessation
- 2006-06-16 EP EP06752809A patent/EP1896588B1/de active Active
- 2006-06-16 CA CA2611054A patent/CA2611054C/en active Active
- 2006-06-16 US US11/921,219 patent/US8323925B2/en active Active
- 2006-06-16 DE DE602006008460T patent/DE602006008460D1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20110300141A1 (en) | 2011-12-08 |
| EP1896588B1 (de) | 2009-08-12 |
| DE602006008460D1 (de) | 2009-09-24 |
| CA2611054C (en) | 2017-05-09 |
| WO2006133566A1 (en) | 2006-12-21 |
| EP1896588A4 (de) | 2008-08-20 |
| EP1896588A1 (de) | 2008-03-12 |
| ES2329511T3 (es) | 2009-11-26 |
| CA2611054A1 (en) | 2006-12-21 |
| US8323925B2 (en) | 2012-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123952T1 (el) | Απομονωση και καθαρισμος αντισωματων αντι-il-13 με την χρηση χρωματογραφιας χημικης συγγενειας πρωτεινης α | |
| EA201000644A1 (ru) | Антитела для лечения и профилактики болезни альцгеймера и их применение | |
| MX2007013626A (es) | Anticuerpos dirigidos contra el peptido beta amiloide y procedimientos que usan los mismos. | |
| DE602005020611D1 (de) | Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen | |
| NO20081233L (no) | Albumin fusjonsproteiner | |
| AU2005253776A8 (en) | Screening methods using c-Abl, Fyn and Syk in combination with tau protein | |
| ATE432281T1 (de) | Pyrrolotriazin-kinasehemmer | |
| DE602006004844D1 (de) | Pyrrolopyrimidine verwendbar als protein kinase inhibitoren | |
| EA200801509A1 (ru) | Человеческие моноклональные антитела к протеинтирозинкиназе 7 ( ptk7) и способы применения антител против ptk7 | |
| DE60032486D1 (de) | Prion protein peptide und deren verwendung | |
| EA200802170A1 (ru) | Лиофилизированная композиция терапевтического пептидного антитела | |
| DK1594833T3 (da) | 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme | |
| ATE433973T1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| WO2007044323A3 (en) | Fusion proteins for blood-brain barrier delivery | |
| WO2005103081A3 (en) | Human monoclonal antibodies against cd20 | |
| MX2009002816A (es) | Proteinas de fusion de albumina. | |
| NO20055209L (no) | Peptabody for cancerbehandling | |
| EA201001695A1 (ru) | Применение эпотилона d для лечения заболеваний, связанных с тау-белком | |
| CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
| AR069860A1 (es) | Metodo para purificar un anticuerpo cd20 | |
| ATE439443T1 (de) | NEUES Aß-BINDUNGSPROTEIN UND DESSEN PEPTIDDERIVATE SOWIE VERWENDUNGEN DAVON | |
| AR047729A1 (es) | Anticuerpos terapeuticos que se unen a la apolipoproteina e (apoe) | |
| EA200801174A1 (ru) | Антитела-миметики glp-2, полипептиды, композиции, способы и применения | |
| WO2008034016A3 (en) | Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins | |
| EA201100071A1 (ru) | Новые композиции и способы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |